Search | IOVS | ARVO Journals

Showing 1 – 20 of 168

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Assessment of pre-existing anti-drug antibodies (ADAs) in pooled serum against novel trispecific biologic RO-104 analogs

Isabel Ray; Alina K Sinha; Li Xu; Peter M Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Parth Patel; Nikhil Gupta; Ashwin Gupta; Megana Paidela; Yixuan Ma; Ramesh Bhatt; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):715.

ARVO Annual Meeting Abstract June 2024

Rat Laser CNV Efficacy Studies with the Novel Trispecific Protein RO-104

Alina K Sinha; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Parth Patel; Nikhil Gupta; Ashwin Gupta; Megana Paidela; Isabel Ray; Yixuan Ma; Ramesh Bhatt; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2163.

ARVO Annual Meeting Abstract June 2024

The comparative efficacy and safety of hypotonic vs isotonic riboflavin for corneal cross-linking in 'thick' keratoconic corneas: a Save Sight Keratoconus Registry study

Stephanie L Watson; Aanchal Gupta; Richard A Mills; Jern Yee Chen; Laurence Sullivan; Andrew Apel; Adam Watson; Marco Abbondanza; Himal Kandel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3865.

ARVO Annual Meeting Abstract June 2024

Inhibition of VEGFA induced HUVEC migration via RO-104, a novel trispecific protein

Yixuan Ma; Alina K Sinha; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Parth Patel; Ashwin Gupta; Nikhil Gupta; Megana Paidela; Isabel Ray; Ramesh Bhatt; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1942.

ARVO Annual Meeting Abstract June 2024

The EC50 binding characteristics of novel trispecific protein, RO-104

Parth Patel; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Alina K Sinha; Nikhil Gupta; Ashwin Gupta; Megana Paidela; Isabel Ray; Yixuan Ma; Jessi Prentice; Ramanath Bhandari; Ramesh Bhatt

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5088.

ARVO Annual Meeting Abstract June 2024

Binding characteristics of a novel trispecific protein RO-104 to aflibercept

Megana Paidela; Li Xu; Peter M Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Parth Patel; Nikhil Gupta; Ashwin Gupta; Alina K Sinha; Isabel Ray; Yixuan Ma; Ramesh Bhatt; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1950.

ARVO Annual Meeting Abstract June 2024

Characterization of the Receptor-Ligand Competition of RO-104 IC50 Potencies

Ashwin Gupta; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Ramesh Bhatt; Parth Patel; Alina K Sinha; Nikhil Gupta; Megana Paidela; Isabel Ray; Yixuan Ma; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):264.

ARVO Annual Meeting Abstract June 2024

Pharmacokinetic Analysis of RO-104 in Rabbit Eye Vitreous

Nikhil Gupta; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Jessi Prentice; Parth Patel; Ashwin Gupta; Alina K Sinha; Megana Paidela; Isabel Ray; Yixuan Ma; Ramesh Bhatt; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):263.

ARVO Annual Meeting Abstract June 2024

PRL3, a novel therapeutic target in neovascular eye diseases

Koon Hwee Ang; Min Thura; Abhishek Gupta; Queenie Shu Woon Hwee Tan; Kam Yew Kuan; Jie Li; Pei Ling Chia; Beiying Qiu; Jimmy Ming Hong; Ke Guo; Xiaomeng Wang; Xinyi Su; Qi Zeng

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1953.

ARVO Annual Meeting Abstract June 2024

Accelerated Retina Organoid Differentiation and Maturation through a Brief Exposure to Electrical Field

Deepthi S. Rajendran Nair; Ege Iseri; Andrea Shehi; Anika Gupta; Anagha Krishnagiri; Stella Quach; Tianyuan Wei; Magdalene J Seiler; Gianluca Lazzi; Biju Thomas

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4545.

ARVO Annual Meeting Abstract June 2024

Longitudinal Analysis of Uveitis: Diagnostic Trends and Disease Trajectory Over a Decade

Kamal Kishore; Gunjan Sharma; Atul Arora; William Rojas-Carabali; Bernett Lee; Amod Gupta; DR. REEMA BANSAL; Mohit Dogra; Deeksha Katoch; Aman Sharma; Ankur Jindal; Deepti Suri; Surjit Singh; Rupesh Vijay Agrawal; DR. VISHALI GUPTA

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6452.

ARVO Annual Meeting Abstract June 2024

Optical coherence tomography angiography findings in non-paraneoplastic autoimmune retinopathy

Khiem Sy Nguyen; Azadeh Mobasserian; Amir Akhavanrezayat; Woong-Sun Yoo; Saeed Mohammadi; Ngoc Than; Negin Yavari; Cigdem Yasar; Anh Ngoc Tram Tran; Dalia El Feky; Jia-Horung Hung; Ankur Sudhir Gupta; Zheng Xian Thng; Irmak Karaca; Frances Andrea Añover; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5572.

ARVO Annual Meeting Abstract June 2024

Importance of repeated aqueous humor analyses in suspected viral anterior uveitis using polymerase chain reaction

Woong-Sun Yoo; Seong-Jae Kim; Li-Ha Kwon; Zheng Xian Thng; Amir Akhavanrezayat; Azadeh Mobasserian; S. Saeed Mohammadi; Ngoc Than; Cigdem Yasar; Anh Ngoc Tram Tran; Khiem Sy Nguyen; Osama Elaraby; Dalia El Feky; Jia-Horung Hung; Ankur Sudhir Gupta; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3022.

ARVO Annual Meeting Abstract June 2024

Evaluation of the effect of modifying indocyanine green solvent on its toxicity to the corneal endothelial cells

Aidan Rubio; Jia-Horung Hung; Sheng-Hsiang Lin; Iou-Jih Hsu; Yi-Sheng Chang; Sheng-Min Hsu; Zheng Xian Thng; Amir Akhavanrezayat; S. Saeed Mohammadi; Woong-Sun Yoo; Cigdem Yasar; Anh Ngoc Tram Tran; Ankur Sudhir Gupta; Li-Wha Wu; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2088.

ARVO Annual Meeting Abstract June 2024

Functional and protein structure analysis of a novel FZD4 mutation c.428T>C in a family with familial exudative vitreoretinopathy

Jia-Horung Hung; Chao-Kai Hsu; Yao-Tsung Chang; Woei-Jer Chuang; Pei-Chi Lin; Yi-Zih Kuo; Zheng Xian Thng; Amir Akhavanrezayat; Azadeh Mobasserian; S. Saeed Mohammadi; Woong-Sun Yoo; Osama Elaraby; Dalia El Feky; Ankur Sudhir Gupta; Li-Wha Wu; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4692.

ARVO Annual Meeting Abstract June 2024

Evaluation of the appropriateness and readability of ChatGPT responses to patient queries on uveitis

Saeed Mohammadi; Anadi Khatri K C; Tanya Jain; Zheng Xian Thng; Woong-Sun Yoo; Negin Yavari; Azadeh Mobasserian; Vahid Bazojoo; Amir Akhavanrezayat; Anh Ngoc Tram Tran; Cigdem Yasar; Osama Elaraby; Ankur Sudhir Gupta; Jia-Horung Hung; Dalia El Feky; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):355.

ARVO Annual Meeting Abstract June 2024

Photopic negative response in uveitis patients using Diopsys® ffERG

Dalia Elfeqi; Amir Akhavanrezayat; Zheng Xian Thng; Aly Khowaja; Woong-Sun Yoo; Azadeh Mobasserian; Saeed Mohammadi; Ngoc Than; Anh Ngoc Tram Tran; Khiem Sy Nguyen; Osama Elaraby; Jia-Horung Hung; Ankur Sudhir Gupta; Anadi Khatri K C; Tanya Jain; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3418.

ARVO Annual Meeting Abstract June 2024

Patient treatment preference in non-infectious intermediate, posterior, panuveitis, episcleritis, or scleritis

Azadeh Mobasserian; Prapatsorn Ongpalakorn; Hashem Ghoraba; Zheng Xian Thng; Negin Yavari; Amir Akhavanrezayat; S. Saeed Mohammadi; Irmak Karaca; Ngoc Trong Tuong Than; Cigdem Yasar; Anh Ngoc Tram Tran; Dalia Elfeqi; Osama Elaraby; Jia-Horung Hung; Ankur Sudhir Gupta; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2598.

ARVO Annual Meeting Abstract June 2024

Impact of Varenicline Solution Nasal Spray on Tear Film Cytokine Levels in Subjects with Sjogren’s Disease

Taylor J. Linaburg; Angela Satya Gupta; Puja Shah; Marian Macsai; Eric Carlson; Emma Iacobucci; Vatinee Y Bunya; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2967.

ARVO Annual Meeting Abstract June 2024

Measuring macular pigment (MP) with visible light Optical Coherence Tomography (OCT) and tailored superluminescent diodes (SLDs)

Alok Kumar Gupta; Ruoyu Meng; Vivek Jay Srinivasan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4331.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Assessment of pre-existing anti-drug antibodies (ADAs) in pooled serum against novel trispecific biologic RO-104 analogs

Rat Laser CNV Efficacy Studies with the Novel Trispecific Protein RO-104

The comparative efficacy and safety of hypotonic vs isotonic riboflavin for corneal cross-linking in 'thick' keratoconic corneas: a Save Sight Keratoconus Registry study

Inhibition of VEGFA induced HUVEC migration via RO-104, a novel trispecific protein

The EC50 binding characteristics of novel trispecific protein, RO-104

Binding characteristics of a novel trispecific protein RO-104 to aflibercept

Characterization of the Receptor-Ligand Competition of RO-104 IC50 Potencies

Pharmacokinetic Analysis of RO-104 in Rabbit Eye Vitreous

PRL3, a novel therapeutic target in neovascular eye diseases

Accelerated Retina Organoid Differentiation and Maturation through a Brief Exposure to Electrical Field

Longitudinal Analysis of Uveitis: Diagnostic Trends and Disease Trajectory Over a Decade

Optical coherence tomography angiography findings in non-paraneoplastic autoimmune retinopathy

Importance of repeated aqueous humor analyses in suspected viral anterior uveitis using polymerase chain reaction

Evaluation of the effect of modifying indocyanine green solvent on its toxicity to the corneal endothelial cells

Functional and protein structure analysis of a novel FZD4 mutation c.428T>C in a family with familial exudative vitreoretinopathy

Evaluation of the appropriateness and readability of ChatGPT responses to patient queries on uveitis

Photopic negative response in uveitis patients using Diopsys® ffERG

Patient treatment preference in non-infectious intermediate, posterior, panuveitis, episcleritis, or scleritis

Impact of Varenicline Solution Nasal Spray on Tear Film Cytokine Levels in Subjects with Sjogren’s Disease

Measuring macular pigment (MP) with visible light Optical Coherence Tomography (OCT) and tailored superluminescent diodes (SLDs)

To View More...

You must be signed into an individual account to use this feature.